Product Information
LACOSAMIDE 200 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2480 per EA under NDC 65862075060. Its NADAC has been published 147 times since Dec 13, 2023.
FDA first approved this application on Jan 5, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862075060
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204994FDA Approved
1/5/2023
TE Code
AB
On Market Since
1/5/2023
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 200 MG TABLET has been published 147 times since Dec 13, 2023, and over the history we have for it it has declined 37.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2480 per EA |
|---|---|
| All-time high | $0.4435 (Mar 13, 2024) |
| All-time low | $0.2466 (Aug 19, 2026) |
| 52-week high | $0.3043 |
| 52-week low | $0.2466 |
| Median price | $0.3040 |
| Average price | $0.3196 |
| Largest weekly change | +31.5% (Aug 21, 2024) |
| Weeks tracked | 147 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lacosamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LACOSAMIDE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 200 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2480 per EA (NDC 65862075060), effective Sep 30, 2026.
How has the price of LACOSAMIDE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 200 MG TABLET has declined 37.5%. It has been tracked across 147 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 200 MG TABLET?
Since Dec 13, 2023, the NADAC for LACOSAMIDE 200 MG TABLET has ranged from a low of $0.2466 (Aug 19, 2026) to a high of $0.4435 (Mar 13, 2024), with a median of $0.3040 per EA.
Are there cheaper alternatives to LACOSAMIDE 200 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LACOSAMIDE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LACOSAMIDE 200 MG TABLET?
LACOSAMIDE 200 MG TABLET (NDC 65862075060) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.